Research Site

Golden, Colorado 80401

1 studies enrolling now · 10 studies all time

What they study most

Acute Coronary Syndrome, Bone Pain in Stage I - III Breast Cancer, COPD, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, Non-Insulin-Dependent, Elevated High-sensitivity C-Reactive Protein (hsCRP), High Risk for Cardiovascular Event, Metastatic Castration-Sensitive Prostate Cancer, Moderate to Very Severe COPD, Non-Small Cell Lung Cancer, Post-Menopausal Osteoporosis, Type 1 Diabetes Mellitus

Studies at this site

• Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS — Recruiting now
• Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents — Running, not enrolling
• Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD — Stopped early
• A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis — Completed
• Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events — Completed
• Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes — Completed
• Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. — Completed
• Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone — Completed
• NOLAN: Naproxen or Loratadine and Neulasta — Completed
• JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events — Stopped early